Proton and particle radiotherapy - a report on the Franco-British seminar on the future of cancer treatment and imaging using new physics-based technologies

British Journal of Radiology

Volumn 82, Issue 975, 2009, Pages 183-189

  Burnet, N G ^a   Kacperek, A ^b   Goodman, S E ^c   Green, S ^d  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b CLATTERBRIDGE CENTRE FOR ONCOLOGY   (United Kingdom)

^c British Embassy   (France)

^d UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON; PROTON;

BRAIN TUMOR; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER THERAPY; CHONDROSARCOMA; CHORDOMA; ENDOCRINE FUNCTION; HUMAN; IMAGING; IN VITRO STUDY; ION THERAPY; IRRADIATION; MEDICAL RESEARCH; MOLECULAR IMAGING; NOTE; PARTICLE RADIATION; PHOTON THERAPY; PROTON THERAPY; RADIATION PHYSICS; RADIOSENSITIVITY; SKULL BASE; TUMOR VOLUME; ARTICLE; FEMALE; FRANCE; MALE; MEDICAL SOCIETY; NEOPLASM; ONCOLOGY; RADIATION DOSE; UNITED KINGDOM;

FEMALE; FRANCE; GREAT BRITAIN; HUMANS; MALE; NEOPLASMS; PROTONS; RADIATION ONCOLOGY; RADIOTHERAPY DOSAGE; SOCIETIES, MEDICAL;

EID: 62449178083     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/26414068     Document Type: Note

References (39)

1. British Embassy in France. Available from: http://www. britishembassy. gov.uk / servlet/Front?pagename=OpenMarket / Xcelerate/ShowPage&c= Page&cid=1203957515018 [Accessed 6 November 2008].
2. Jones B. The potential clinical advantages of charged particle radiotherapy using protons or light ions. Clin Oncol (R Coll Radiol) 2008;20:555-63.
3. Jones B, Burnet N. Radiotherapy for the future. Protons and ions hold much promise. BMJ 2005;330:979-80.
4. Lundkvist J, Ekman M, Ericsson SR, Joönsson B, Glimelius B. Proton therapy of cancer: potential clinical advantages and cost-effectiveness. Acta Oncol 2005;44:850-61.
5. Schulz-Ertner D, Tsujii H. Particle radiation therapy using proton and heavier ion beams. J Clin Oncol 2007;25:953-64.
6. Lodge M, Pijls-Johannesma M, Stirk L, Munro AJ, De Ruysscher D, Jefferson T. A systematic literature review of the clinical and cost-effectiveness of hadron therapy in cancer. Radiother Oncol 2007;83:110-22.
7. Schulz-Ertner D, Karger CP, Feuerhake A, Nikoghosyan A, Combs SE, Jaökel O, et al. Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas. Int J Radiat Oncol Biol Phys 2007;68:449-57.
8. Noeöl G, Feuvret L, Calugaru V, Dhermain F, Mammar H, Haie-Méder C, et al. Chordomas of the base of the skull and upper cervical spine. One hundred patients irradiated by a 3D conformal technique combining photon and proton beams. Acta Oncol 2005;44:700-8.
9. Terahara A, Niemierko A, Goitein M, Finkelstein D, Hug E, Liebsch N, et al. Analysis of the relationship between tumor dose inhomogeneity and local control in patients with skull base chordoma. Int J Radiat Oncol Biol Phys 1999;45:351-8.
10. Habrand JL, Schneider R, Alapetite C, Feuvret L, Petras S, Datchary J, et al. Proton therapy in pediatric skull base and cervical canal low-grade bone malignancies. Int J Radiat Oncol Biol Phys 2008;71:672-5.
11. Rutz HP, Weber DC, Goitein G, Ares C, Bolsi A, Lomax AJ, et al. Postoperative spot-scanning proton radiation therapy for chordoma and chondrosarcoma in children and adoles cents: initial experience at Paul Scherrer Institute. Int J Radiat Oncol Biol Phys 2008;71:220-5.
12. St Clair WH, Adams JA, Bues M, Fullerton BC, La Shell S, Kooy HM, et al. Advantage of protons compared to conventional X-ray or IMRT in the treatment of a pediatric patient with medulloblastoma. Int J Radiat Oncol Biol Phys 2004;58:727-34.
13. Jones B, Price P, Burnet NG, Roberts JT. Modelling the expected increase in demand for particle radiotherapy: implications for the UK. Br J Radiol 2005;78:832-5.
14. Jones B, Green S, Dale RG, Peach K, Kirkby K. Particle radiotherapy in the UK. Clin Oncol (R Coll Radiol) 2008;20:67-8.
15. Carabe-Fernandez A, Dale RG, Jones B. The incorporation of the concept of minimum RBE (RbEmin) into the linear-quadratic model and the potential for improved radio-biological analysis of high-LET treatments. Int J Radiat Biol 2007;83:27-39.
16. ARCHADE. Available from: http://www.archade.fr [Accessed 6 November 2008]
17. IBA. Available from: http://www.iba.be [Accessed 6 November 2008]
18. Available from: http://lyoinfo.in2p3.fr/rapport0001/p97-98.pdf [Accessed 6 November 2008]
19. Institut Curie. Available from: http://protontherapie.cur-ie.info/ [Accessed 6 November 2008]
20. Noeöl G, Bollet MA, Calugaru V, Feuvret L, Haie-Meder C, Dhermain F, et al. Functional outcome of patients with benign meningioma treated by 3D conformal irradiation with a combination of photons and protons. Int J Radiat Oncol Biol Phys 2005;62:1412-22.
21. CONFORM - the COnstruction of a Non-scaling FFAG for Oncology, Research and Medicine. Available from: http:// www.conform.ac.uk/ [Accessed 6 November 2008]
22. EMMA: the first NS-FFAG. Available from: http://www.hep.man.ac.uk/u/ roger/talks/2006/17.ppt [Accessed 6 November 2008]
23. Amplitude technologies. Available from: http://www.am-plitude- technologies.com [Accessed 6 November 2008]
24. LIBRA. Available from: http://www.libra-bt.co.uk/ [Accessed 6 November 2008]
25. The Ion Beam network. Available from: http://www.ion-beamnetwork.co.uk/ [Accessed 6 November 2008]
26. Surrey Ion Beam Centre. Available from: http://www.ee. surrey.ac.uk/IBC/ [Accessed 6 November 2008]
27. Folkard M, Prise KM, Grime G, Kirkby K, Vojnovic B. The use of microbeams to investigate radiation damage in living cells. Appl Radiat Isot 2008, Jun 22 [Epub ahead of print].
28. Arronax. Available from: http://www.cyclotron-nantes.fr/ [Accessed 6 November 2008].
29. Haddad F, Ferrer L, Guertin A, Carlier T, Michel N, Barbet J, et al. ARRONAX, a high-energy and high-intensity cyclotron for nuclear medicine. Eur J Nucl Med Mol Imaging 2008;35:1377-87.
30. Burnet NG, Thomas SJ, Burton KE, Jefferies SJ. Defining the tumour and target volumes for radiotherapy. Cancer Imaging 2004;4:1-9.
31. Ducongé F, Pons T, Pestourie C, Hérin L, Thécolonzeampersandecute; B, Gombert K, et al. Fluorine-18-labeled phospholipid quantum dot micelles for in vivo multimodal imaging from whole body to cellular scales. Bioconjug Chem 2008;19:1921-6.
32. Maroy R, Boisgard R, Comtat C, Frouin V, Cathier P, Duchesnay E, et al. Segmentation of rodent whole-body dynamic PET images: an unsupervised method based on voxel dynamics. IEEE Trans Med Imaging 2008;27:342-54.
33. Philippe FD, Prada C, de Rosny J, Clorennec D, Minonzio JG, Fink M. Characterization of an elastic target in a shallow water waveguide by decomposition of the time-reversal operator. J Acoust Soc Am 2008;124:779-87.
34. Laboratoire Ondes et Acoustique. Available from: http:// www.loa.espci.fr/LOA-Main-en.htm [Accessed 6 November 2008]
35. Laboratoire de l Accélérateur Linéaire. Available from: http://www.lal.in2p3.fr/ [Accessed 6 November 2008]
36. Gray Institute for Radiation Oncology and Biology. Available from: http://www.rob.ox.ac.uk [Accessed 6 November 2008].
37. Flaccavento G, Folkard M, Noble JA, Prise KM, Vojnovic B. Substrate evaluation for a microbeam endstation using unstained cell imaging. Appl Radiat Isot 2008, Jun 22 [Epub ahead of print].
38. Jena R, Price SJ, Baker C, Jefferies SJ, Pickard JD, Gillard JH, et al. Diffusion tensor imaging: possible implications for radiotherapy treatment planning of patients with high-grade glioma. Clin Oncol 2005;17:581-90.
39. European Society for Therapeutic Radiology and Oncology. Available from: http://www.estro.be [Accessed 6 November 2008].